Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Rheumatic Diseases Clinics of North America
|
November 21, 2000
Reciprocal interactions between the neuroendocrine and immune systems during inflammation
I C Chikanza, A B Grossman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 5, 2001
Targeting tumour necrosis factor in the treatment of rheumatoid arthritis
G J Pearce, I C Chikanza
Rheumatology International
|
September 16, 2023
Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases
Lazaros I Sakkas, Ian C Chikanza
East African Medical Journal
|
April 1, 1989
Chlorpromazine and frusemide in the acute management of severe hypertension
I C Chikanza, P N Okwanga
Clinical Rheumatology
|
April 8, 2026
Chimeric antigen receptor macrophage (CAR-M) immunotherapy in autoimmune inflammatory rheumatic diseases
Ian C Chikanza, Lazaros I Sakkas
Clinical Rheumatology
|
April 18, 2026
Cell immunotherapy in autoimmune rheumatic diseases: a paradigm shift in the therapy of autoimmune inflammatory rheumatic diseases
Ian C Chikanza, Lazaros I Sakkas
Annals of the New York Academy of Sciences
|
March 28, 2001
Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications
I C Chikanza, P Petrou, G Chrousos
The Journal of Endocrinology
|
December 6, 2003
The molecular and cellular basis of corticosteroid resistance
I C Chikanza, D Kozaci, Y Chernajovsky
Rheumatic Diseases Clinics of North America
|
November 21, 2000
The influence of the hormonal system on pediatric rheumatic diseases
I C Chikanza, W Kuis, C J Heijnen
Clinical Rheumatology
|
April 6, 2026
Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE)
Ian C Chikanza, Christina Katsiari, Lazaros I Sakkas
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Rheumatic Diseases Clinics of North America
|
November 21, 2000
Reciprocal interactions between the neuroendocrine and immune systems during inflammation
I C Chikanza, A B Grossman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 5, 2001
Targeting tumour necrosis factor in the treatment of rheumatoid arthritis
G J Pearce, I C Chikanza
Rheumatology International
|
September 16, 2023
Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases
Lazaros I Sakkas, Ian C Chikanza
East African Medical Journal
|
April 1, 1989
Chlorpromazine and frusemide in the acute management of severe hypertension
I C Chikanza, P N Okwanga
Clinical Rheumatology
|
April 8, 2026
Chimeric antigen receptor macrophage (CAR-M) immunotherapy in autoimmune inflammatory rheumatic diseases
Ian C Chikanza, Lazaros I Sakkas
Clinical Rheumatology
|
April 18, 2026
Cell immunotherapy in autoimmune rheumatic diseases: a paradigm shift in the therapy of autoimmune inflammatory rheumatic diseases
Ian C Chikanza, Lazaros I Sakkas
Annals of the New York Academy of Sciences
|
March 28, 2001
Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications
I C Chikanza, P Petrou, G Chrousos
The Journal of Endocrinology
|
December 6, 2003
The molecular and cellular basis of corticosteroid resistance
I C Chikanza, D Kozaci, Y Chernajovsky
Rheumatic Diseases Clinics of North America
|
November 21, 2000
The influence of the hormonal system on pediatric rheumatic diseases
I C Chikanza, W Kuis, C J Heijnen
Clinical Rheumatology
|
April 6, 2026
Potential of chimeric antigen receptor (CAR) T cell immunotherapy in systemic lupus erythematosus (SLE)
Ian C Chikanza, Christina Katsiari, Lazaros I Sakkas
Page
of 5